Transgene Biotek Ltd Schedules Board Meeting to Discuss Quarterly Results and AGM Extension
Transgene Biotek Ltd has scheduled a meeting of its Board of Directors for Friday, August 07, 2026, to consider several critical corporate matters. The agenda includes reviewing the company's recent financial performance, internal auditing requirements, and seeking an extension for the Annual General Meeting (AGM).The proposed board meeting is set to address the following key items:
- Approval of the N-Audited Financial Results (Standalone and Consolidated) for the quarter ending June 30, 2026.
- Consideration and approval of the Limited Review Report (Standalone and Consolidated) for the quarter ended June 30, 2026.
- Approval for seeking an extension of time to hold the Annual General Meeting (AGM) for the Financial Year 2025-26.
- Consideration and approval for the appointment of the internal auditor for the financial year 2026-27.
The company's management will also transact any other business deemed necessary during the board meeting.
Insider Trading Status Update
Regarding insider trading procedures, Transgene Biotek Ltd confirmed that the Trading Window for dealing in the securities of the company was closed from July 1, 2026. This window remains closed until 48 hours after the financial results for the quarter ended on June 30, 2026 become generally available information.Stock Price Movement
Transgene Biotek Ltd shares settled at ₹2.94 in post-market trading today, having dipped by 1.34%. Throughout the day, the stock moved through a dynamic range, testing a high of ₹3.07 but finding support near the low of ₹2.93.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.